Why Intuitive Surgical (ISRG) Stock Is Up Today

NEW YORK (TheStreet) -- Intuitive Surgical Inc.  (ISRG) is up 10% to $482 in heavy trading Tuesday. So far today, 1.58 million shares exchanged hands, triple the stock's daily average of 508,000.

Today's bump comes following the company's announcement that the FDA had approved its da Vinci Xi surgical system.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

The company describes the robotic surgical system as "a technological leap forward in replacing large-incision abdominal surgeries (open surgery) with a minimally invasive approach."

"The da Vinci Xi System's new overhead architecture means that multi-quadrant surgery can be performed without repositioning the system, an innovation long sought by surgeons who perform complex procedures. We strive to provide the most advanced, least invasive option for surgery, and we are working hard to make minimally invasive surgery the standard of care," said Gary Guthart, company'president and CEO.

Having won approval from U.S. regulators, the company now plans to seek clearance to market the technology worldwide.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you liked this article you might like

Five Rules for This Market Beast: Cramer's 'Mad Money' Recap (Tues 1/16/18)

Five Rules for This Market Beast: Cramer's 'Mad Money' Recap (Tues 1/16/18)

Warren Buffett Has $100 Billion to Spend, What's He Going to Buy?

Warren Buffett Has $100 Billion to Spend, What's He Going to Buy?

The Method to My Investing Madness: Cramer's 'Mad Money' Recap (Tues 12/26/17)

The Method to My Investing Madness: Cramer's 'Mad Money' Recap (Tues 12/26/17)

CVS Health, Intuitive Surgical, Allergan: 'Mad Money' Lightning Round

CVS Health, Intuitive Surgical, Allergan: 'Mad Money' Lightning Round

Long Live the FAANNG Stocks: Cramer's 'Mad Money' Recap (Tuesday 12/19/17)

Long Live the FAANNG Stocks: Cramer's 'Mad Money' Recap (Tuesday 12/19/17)